Catalyst Pharmaceuticals, Inc. (CPRX) NASDAQ
31.27
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
31.27
+0(+0.00%)
Currency In USD
| Market Cap | 2.85B |
| Enterprise Value | 2.15B |
| P/E Ratio | 17.27 |
| PEG Ratio | 2.05 |
| Price/Sales Ratio | 6.41 |
| Price/Book Ratio | 3.77 |
| Enterprise/Revenue | 5.15 |
| Enterprise/EBITDA | 9.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.37 |
| Operating Margin | 0.45 |
| Return On Assets | 0.19 |
| Return On Equity | 0.24 |
| Revenue | 588.99M |
| Revenue/Share | 4.88 |
| Gross Profit | 501.74M |
| EBITDA | 295.65M |
| Net Income | 214.33M |
| Diluted EPS | 1.68 |
| Total Cash | 755.86M |
| Total Cash/Share | 6.18 |
| Total Debt | 2.68M |
| Total Debt/Equity | 0 |
| Current Ratio | 7.1 |
| Book Value Per Share | 8.28 |
| 52-Week Change | 25.53 |
| 52-Week High | 32.56 |
| 52-Week Low | 19.05 |
| Moving Average 50 Days | 28 |
| Moving Average 200 Days | 23.77 |
| Average Volume | 2.07M |
| Shares Outstanding | 122.38M |
| % Held by Institutions | 85.22 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |